share_log
Benzinga ·  May 7 07:26
Entrada Therapeutics Q1 2024 GAAP EPS $0.68 May Not Be Comparable To $(0.52) Estimate, Sales $59.120M May Not Be Comparable To $14.977M Estimate
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment